SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-292484
Filing Date
2014-08-04
Accepted
2014-08-04 08:02:59
Documents
3
Period of Report
2014-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d766598d8k.htm 8-K 17604
2 EX-99.1 d766598dex991.htm EX-99.1 68607
3 GRAPHIC g766598g86m66.gif GRAPHIC 2987
  Complete submission text file 0001193125-14-292484.txt   91789
Mailing Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 617-513-9882
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 141011515
SIC: 2834 Pharmaceutical Preparations